Hos de behandlingsnaive mRCC- patienter, der fik IFN- α, forekom 6 (2%) tromboemboliske hændelser; 1 patient (< 1%) oplevede en grad 3 DVT, og 5 patienter (1%) fik lungeemboli, 1 med grad 1 og 4 med grad 4.
In treatment-naïve MRCC patients receiving IFN-α, six (2%) venous thromboembolic events occurred; one patient (< 1%) experienced a Grade 3 DVT and five patients (1%) had pulmonary embolisms, one with Grade 1 and four with Grade 4.